SUNPHARMA - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.5
Show all parameters (20 more)
🧾 Trade Setup
Buy Price: 1,850 ₹. Initial Stop Loss: 1,830 ₹. Target Level 1: 1,900 ₹ – based on momentum and the recent EPS growth. Target Level 2: 1,940 ₹ - contingent upon maintaining volume above the 7-day average. This is a short-term play capitalizing on positive momentum; monitor closely for any signs of profit-taking or increased selling pressure around the 1,900 level.
✅ Positive
Strong PAT growth in the last quarter (22.8% Qtr Profit Variance) and a significant increase in EPS (12.5 ₹) are driving immediate upward momentum. Furthermore, the FII holding is decreasing (-1.40%) suggesting growing investor confidence.
⚠️ Limitation
The extremely high Stock P/E of 138 relative to the Industry PE of 34.8 indicates a substantial premium valuation – this represents a significant risk if today's volume doesn’t justify the price increase, and could trigger profit-taking. The negative MACD (-21.0) also suggests underlying selling pressure that needs confirmation.
🏭 Industry
The pharmaceutical sector is generally bullish due to ongoing mergers and acquisitions activity (as evidenced by the Taro deal), but investor sentiment remains sensitive to regulatory developments and drug pricing pressures.